Monographs: Dosage forms: Specific monographs: Dextromethorphan oral solution (Dextromethorphani solutio peroralum)

Category. Antitussive.

Storage. Dextromethorphan oral solution should be kept in well-closed container, protected from light.

Additional information. Strengths available may range from 15 mg to 30 mg per 10 mL.

Requirements

Complies with the monograph for Liquid preparations for oral use.

Definition. Dextromethorphan oral solution is a solution of Dextromethorphan hydrobromide in a suitable vehicle, which may be flavoured. It contains not less than 90.0% and not more than 110.0% of the amount of Dextromethorphan hydrobromide (C18H25NO.HBr.H2O) stated on the label.

Manufacture. The selection of the active ingredient ensures that the oral solution, if tested, would comply with a limit of not more than 0.1% for levomethorphan hydrobromide. A suitable levomethorphan limit test for dextromethorphan oral solutions (and other dextromethorphan finished pharmaceutical products) is published in the Supplementary information section.

Identity tests

  • Either tests A and B or test B together with any one of tests C or D may be applied.

Transfer a quantity of the oral solution containing about 75 mg of Dextromethorphan hydrobromide to a 250 mL separating funnel, add 20 mL of water R, 5 mL of sodium hydroxide (~100 g/L) TS, 40 mL of hexane R and shake thoroughly. Remove the hexane layer and filter through anhydrous sodium sulfate R into a beaker. Repeat the extraction using two 40 mL portions of hexane R and collecting the extracts in the beaker after filtering. Evaporate the combined extracts and dissolve the residue in 30 mL of dichloromethane R. Use the test solution for “Identity tests” A, B and D.

A. Evaporate 10 mL of the test solution to dryness and carry out the examination with the dried residue as described under 1.7 Spectrophotometry in the infrared region. The infrared absorption spectrum is concordant with the spectrum obtained from dextromethorphan hydrobromide RS treated similarly or with the reference spectrum of dextromethorphan.

B. Use 10 mL of the test solution to determine the optical rotation (1.4); the substance is dextrorotatory.

C. Carry out the test as described under 1.14.1 Chromatography, High-performance liquid chromatography using the same chromatographic conditions as described under “Assay”. The retention time of the principal peak in the chromatogram obtained with solution (1) is similar to that in the chromatogram obtained with solution (2).

D. Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography using silica gel R5 as the coating substance and a mixture of 2 volumes of ammonia (~260 g/L) TS, 10 volumes of dichloromethane R, 13 volumes of methanol R, 20 volumes of ethyl acetate R and 55 volumes of toluene R as the mobile phase. Apply separately to the plate 5 µL of each of the following three solutions. For solution (A) use the test solution. For solution (B) use about 2.5 mg of dextromethorphan hydrobromide RS per mL of methanol R. For solution (C) use about 2.5 mg of dextromethorphan hydrobromide RS and 2.5 mg of pentoxyverine citrate R per mL of methanol R. After removing the plate from the chromatographic chamber allow it to dry in air. Spray the plate with potassium iodobismuthate TS1 and examine the chromatogram in daylight.

The test is not valid unless the chromatogram obtained with solution (C) shows two clearly separated spots. The principal spot obtained with solution (A) corresponds in position, appearance and intensity with that obtained with solution (B).

pH value (1.13). pH of the oral solution, 4.0–6.0.

Related substances

Carry out the test as described under 1.14.1 Chromatography, High-performance liquid chromatography using the same chromatographic conditions as described under “Assay”.

Prepare the following solutions in mobile phase. For solution (1) transfer a volume of the oral solution, equivalent to about 210 mg of Dextromethorphan hydrobromide, into a 200 mL volumetric flask, make up to volume, shake and filter. For solution (2) dilute 2.0 mL of solution (1) to 200.0 mL. For solution (3) use a solution containing about 40 µg of dextromethorphan hydrobromide RS and about 40 µg of dextromethorphan impurity A RS per mL.

Inject 20 µL of solution (3). The test is not valid unless the resolution between the peaks due to dextromethorphan (retention time about 22 min) and impurity A (with a relative retention of about 1.1) is at least 1.5.

Inject alternately 20 µL each of solutions (1) and (2) and record the chromatograms for about twice the retention time of dextromethorphan.

In the chromatogram obtained with solution (1) the following impurities, if present, are eluted at the following relative retention with reference to dextromethorphan: impurity B about 0.4; impurity C about 0.8; impurity D/ F about 0.9; and impurity A about 1.1.

In the chromatogram obtained with solution (1):

  • the area of any peak corresponding to either impurity A, impurity B or the sum of the areas of the peaks corresponding to impurity D and F (impurity D and impurity F may co-elute) is not greater than the 0.5 times the area of the principal peak obtained with solution (2) (0.5 %);
  • the area of any peak corresponding to impurity C, when multiplied by a correction factor of 0.2, is not greater than 0.5 times the area of the principal peak obtained with solution (2) (0.5%);

Assay. Carry out the test as described under 1.14.1 Chromatography, High-performance liquid chromatography using a stainless steel column (25 cm x 4.6 mm), packed with particles of silica gel, the surface of which has been modified with chemically-bonded octadecylsilyl group (5 µm).

Prepare the mobile phase by dissolving 3.11 g of docusate sodium R in a mixture of 400 mL of water R and 600 mL of acetonitrile R. Add 0.56 g of ammonium nitrate R and adjust to an apparent pH 2.0 with glacial acetic acid R.

Operate with a flow rate of 1.0 mL per minute. As a detector use an ultraviolet spectrophotometer set at a wavelength of about 280 nm.

Prepare the following solutions in mobile phase.

For solution (1) transfer a weighed quantity of the oral solution, containing the equivalent of about 37.5 mg of Dextromethorphan hydrobromide, into a 50 mL volumetric flask, make up to volume, shake and filter. For solution (2) use 0.75 mg of dextromethorphan hydrobromide RS per mL.

Inject alternatively 20 µL each of solution (1) and (2) and record the chromatograms.

Measure the areas of the peaks corresponding to dextromethorphan obtained in the chromatograms. Determine the weight per mL (1.3.1) of the oral solution and calculate the percentage content of Dextromethorphan hydrobromide (C18H25NO.HBr.H2O), weight in volume, of the oral solution, using the declared content of C18H25NO.HBr in dextromethorphan hydrobromide RS. Each mg of C18H25NO.HBr is equivalent to 1.0511 mg of C18H25NO.HBr.H2O.

Impurities

The impurities limited by the requirements of this monograph include impurities A, B, C, D and F listed in the monograph for Dextromethorphan hydrobromide.

to previous sectionto next section